Progress and prospects: stem cells and neurological diseases

被引:92
作者
Goegel, S. [1 ]
Gubernator, M. [1 ]
Minger, S. L. [1 ]
机构
[1] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 9RT, England
关键词
cell replacement therapy; stem cells; Parkinson's disease; ischaemic stroke; Huntington's disease; DOPAMINERGIC-NEURONS; HUNTINGTONS-DISEASE; NEURAL TRANSPLANTS; THERAPY; GENE; PARKINSONS; DIFFERENTIATION; PROLIFERATION; PRECURSORS; EXPRESSION;
D O I
10.1038/gt.2010.130
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The central nervous system has limited capacity of regenerating lost tissue in slowly progressive, degenerative neurological conditions such as Parkinson's disease (PD), Alzheimer's disease or Huntington's disease (HD), or in acute injuries resulting in rapid cell loss for example, in cerebrovascular damage (for example, stroke) or spinal cord injury. Although the adult brain contains small numbers of stem cells in restricted areas, they do not contribute significantly to functional recovery. Transplantation of stem cells or stem cell-derived progenitors has long been seen as a therapeutic solution to repair the damaged brain. With the advent of the induced pluripotent stem cells technique a new and potentially better source for transplantable cells may be available in future. This review aims to highlight current strategies to replace lost cellular populations in neurodegenerative diseases with the focus on HD and PD and traumatic brain injuries such as stroke, discussing many of the technical and biological issues associated with central nervous system cell transplantation. Gene Therapy (2011) 18, 1-6; doi: 10.1038/gt.2010.130; published online 30 September 2010
引用
收藏
页码:1 / 6
页数:6
相关论文
共 41 条
[1]
Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo [J].
Anderson, Lucy ;
Burnstein, Rowan M. ;
He, Xiaoling ;
Luce, Richard ;
Furlong, Rob ;
Foltynie, Tom ;
Sykacek, Peter ;
Menon, David K. ;
Caldwell, Maeve A. .
EXPERIMENTAL NEUROLOGY, 2007, 204 (02) :512-524
[2]
Potential of adult neural stem cells in stroke therapy [J].
Andres, Robert H. ;
Choi, Raymond ;
Steinberg, Gary K. ;
Guzman, Raphael .
REGENERATIVE MEDICINE, 2008, 3 (06) :893-905
[3]
Autologous mesenchymal stem cell transplantation in stroke patients [J].
Bang, OY ;
Lee, JS ;
Lee, PH ;
Lee, G .
ANNALS OF NEUROLOGY, 2005, 57 (06) :874-882
[4]
Optimizing the success of cell transplantation therapy for stroke [J].
Bliss, Tonya M. ;
Andres, Robert H. ;
Steinberg, Gary K. .
NEUROBIOLOGY OF DISEASE, 2010, 37 (02) :275-283
[5]
HISTOLOGICAL FINDINGS ON FETAL STRIATAL GRAFTS IN A HUNTINGTON'S DISEASE PATIENT EARLY AFTER TRANSPLANTATION [J].
Capetian, P. ;
Knoth, R. ;
Maciaczyk, J. ;
Pantazis, G. ;
Ditter, M. ;
Bokla, L. ;
Landwehrmeyer, G. B. ;
Volk, B. ;
Nikkhah, G. .
NEUROSCIENCE, 2009, 160 (03) :661-675
[6]
Carpenter M, 2006, METH MOL B, V331, P153
[7]
Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats [J].
Chen, B. ;
Gao, X. -Q. ;
Yang, C. -X. ;
Tan, S. -K. ;
Sun, Z-L ;
Yan, N. -H. ;
Pang, Y. -G. ;
Yuan, M. ;
Chen, G. -J. ;
Xu, G. -T. ;
Zhang, K. ;
Yuan, Q. L. .
BRAIN RESEARCH, 2009, 1284 :1-11
[8]
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration [J].
Cicchetti, F. ;
Saporta, S. ;
Hauser, R. A. ;
Parent, M. ;
Saint-Pierre, M. ;
Sanberg, P. R. ;
Li, X. J. ;
Parker, J. R. ;
Chu, Y. ;
Mufson, E. J. ;
Kordower, J. H. ;
Freeman, T. B. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (30) :12483-12488
[9]
Emerging restorative treatments for Parkinson's disease [J].
Deierborg, Tomas ;
Soulet, Denis ;
Roybon, Laurent ;
Hall, Vanessa ;
Brundin, Patrik .
PROGRESS IN NEUROBIOLOGY, 2008, 85 (04) :407-432
[10]
Stem cell transplantation for Huntington's disease [J].
Dunnett, Stephen B. ;
Rosser, Anne E. .
EXPERIMENTAL NEUROLOGY, 2007, 203 (02) :279-292